Mayne soars on earnings lift and share price gallivants north
SYDNEY: Mayne Pharma expects underlying earnings for the first half to be up to 300
SYDNEY: Mayne Pharma expects underlying earnings for the first half to be up to 300
FEATURED
Pharmacy sector increasingly muscling into beauty business
Shop top apartment plan aimed at boomer market
Boomers are enjoying their retirement unless they’re renting claims survey
Collaborative approach to innovative multigenerational housing project unveiled
Palliative care group breaks ground on new era facility
Major hotel brand set to take elderly hospital patients
INNOVATION
